Machina Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Machina Capital’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Buy	3,827 +3,183	+494%	+$2.17M	0.38%	95
2026 Q1	$498K	Sell	644 -963	-60%	-$737K	0.1%	239
2025 Q4	$1.24M	Sell	1,607 -3,008	-65%	-$2.04M	0.24%	151
2025 Q3	$2.59M	Buy	+4,615	New	+$2.61M	0.46%	84
2025 Q2	–	Sell	-2,522	Closed	-$1.6M	–	382
2025 Q1	$1.6M	Buy	2,522 +131	+5%	+$90.1K	0.47%	76
2024 Q4	$1.7M	Buy	2,391 +1,874	+362%	+$1.57M	0.72%	34
2024 Q3	$543K	Buy	517 +184	+55%	+$205K	0.22%	161
2024 Q2	$350K	Sell	333 -974	-75%	-$944K	0.16%	209
2024 Q1	$1.26M	Sell	1,307 -304	-19%	-$289K	0.66%	37
2023 Q4	$1.41M	Buy	1,611 +889	+123%	+$732K	0.91%	14
2023 Q3	$594K	Buy	+722	New	+$567K	0.33%	118
2023 Q2	–	Sell	-611	Closed	-$502K	–	477
2023 Q1	$502K	Buy	+611	New	+$461K	0.44%	74
2022 Q4	–	Sell	-536	Closed	-$369K	–	199
2022 Q3	$369K	Sell	536 -504	-48%	-$317K	0.78%	49
2022 Q2	$615K	Buy	+1,040	New	+$676K	1.38%	12
2021 Q2	–	Sell	-457	Closed	-$216K	–	171
2021 Q1	$216K	Buy	+457	New	+$223K	2.46%	29
2019 Q4	–	Sell	-1,726	Closed	-$479K	–	423
2019 Q3	$479K	Sell	1,726 -1,909	-53%	-$565K	0.22%	157
2019 Q2	$1.14M	Buy	3,635 +2,953	+433%	+$983K	0.43%	75
2019 Q1	$280K	Buy	+682	New	+$281K	0.11%	213

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Machina Capital's REGN Position: Q2 2026 in Review

Machina Capital increased its Regeneron Pharmaceuticals (REGN) stake by 494% in Q2 2026, buying an estimated $2.17M and bringing the position to 3,827 shares worth $2.39M. The position accounts for 0.38% of the portfolio, ranked #95.

Machina Capital first reported a position in REGN in Q1 2019 and has held it in 18 quarters since. The position peaked at $2.59M in Q3 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Machina Capital held 3,827 shares of Regeneron Pharmaceuticals worth $2.39M as of Q2 2026.
Machina Capital bought 3,183 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.17M.
Regeneron Pharmaceuticals made up 0.38% of Machina Capital's portfolio in Q2 2026, its #95 holding.
Machina Capital first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 18 quarters since.
Machina Capital's Regeneron Pharmaceuticals position peaked at $2.59M in Q3 2025.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Machina Capital's 13F filing for Q2 2026, filed 10 Aug 2026.